A clinical stage pharma company needed to assess it business opportunity for its first topical drug.
MSC performed a high-level indication assessment of two large dermatology indications to determine the client’s strategic fit with current treatment algorithms, physician’s decision trees and prescription patterns on the target markets. Extensive reports were written for each of the indications where drug developing companies along with competitive intelligence about development pipelines, MOAs and recent financial deals were positioned in relation to the client’s envisioned TPP. To verify the strategic fit of the client’s envisioned TPP with the unmet clinical need, interviews were conducted with general physicians at primary wards, dermatologists and patient organizations. Based on the need assessment, competitive landscape and prescription norms, a solid foundation for a business plan could be crafted.